Filing Details
- Accession Number:
- 0001209191-23-049782
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-18 17:09:21
- Reporting Period:
- 2023-09-15
- Accepted Time:
- 2023-09-18 17:09:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1178879 | Amicus Therapeutics Inc. | FOLD | Pharmaceutical Preparations (2834) | 200422823 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1400973 | F John Crowley | C/O Amicus Therapeutics, Inc. 3675 Market Street Philadelphia PA 19104 | Executive Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-09-15 | 6,044 | $13.06 | 914,009 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 64,895 | Indirect | By Trust |
Footnotes
- This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $12.93 to $13.22 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.